Publication date: Apr 11, 2019 Marshall, T.L. and Reinhardt, J.P. Pain Management in the Last 6 Months of Life: Predictors of Opioid and Non-Opioid Use. 03381. 2019 J Am Med ... Read more

Publication date: Apr 12, 2019 Children represent a patient demographic composed of multiple, unique subpopulations differentiated by rapidly changing age-related physiology, which includes the means of metabolizing opioids. Opioids are ... Read more

Publication date: Apr 12, 2019 Neuraxial-spinal and epidural-administration of opioids can be an effective method for controlling pain for children in a number of clinical settings. Understanding the basic pharmacologic ... Read more

Publication date: Apr 12, 2019 The entire field of medicine, not just anesthesiology, has grown comfortable with the risks posed by opioids; but these risks are unacceptably high. It is ... Read more

Publication date: Apr 12, 2019 The increase in opioid-related deaths in the United States (and other countries) has prompted a national debate in medicine about the appropriateness of opioids for ... Read more

Publication date: Apr 12, 2019 Management of acute pain in children is fundamental to our practice. Its myriad benefits include reduced suffering, improved patient satisfaction, more rapid recovery, and a ... Read more

Publication date: Apr 12, 2019 The opioid crisis in America affects both adults and children. However, knowledge about the epidemiology of the opioid crisis, opioid prescribing patterns, and the link ... Read more

Publication date: Apr 12, 2019 Opioid medications are an important tool in the management of pain and have been used in clinical practice for centuries. However, due to the highly ... Read more

Publication date: Apr 13, 2019 Opioids are a mainstay of acute pain management but can have many adverse effects, contributing to problematic long-term use. Opioid tolerance (increased dose needed for ... Read more

Publication date: Apr 12, 2019 Extended-release naltrexone (XR-NTX, Vivitrol(R)) and daily oral naltrexone tablets (O-NTX) are FDA-approved mu opioid receptor antagonist medications for alcohol dependence treatment. Despite the efficacy of ... Read more